| Ytd | 7.68% | |
| 1y | -42.02% |
| Open | 0.95 | Prev Close | 0.96 | Low | 0.94 | High | 1.00 | Mkt Cap | 58.04M |
| Vol | 832.00 | Avg Vol | 47.31K | EPS | -0.43 | P/E | -2.26 | Forward P/E | -1.21 |
| Beta | 1.40 | Short Ratio | 0.73 | Inst. Own | 11.61% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 0.98 | 200-d Avg | 1.00 | 1yr Est | 33.56 |
INCR News
NEW YORK & HERZLIYA, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE:
First Tranche Closing (50%) of Botanico Transaction Expands International Platform with Exclusive Ac
The Company reported over NIS 270 million in revenue, NIS 37 million in Net loss, NIS 47 million in
NEW YORK and HERZLIYA, Israel, March 03, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TAS
InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EB
InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EB
InterCure Ltd. (NASDAQ: INCR - Get Free Report)'s stock price fell 6.6% during trading on Tuesday. T
https://abcnews.go.com/Politics/trump-sign-executive-order-reclassifying-marijuana-officials/story?i
InterCure (NASDAQ: INCR - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both medi
InterCure Ltd. (NASDAQ: INCR - Get Free Report) shares were up 0.7% during mid-day trading on Friday
Agreements formalize research partnership combining InterCure's global pharmaceutical platform with
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, d
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, d
Acquisition of leading cannabis company marks major milestone in InterCure's commercial expansion st
2024 results were affected by damages to our southern facility caused by the terrorist attack on Oct
NEW YORK and HERZLIYA, Israel , Feb. 12, 2025 /PRNewswire/ -- InterCure Ltd. (NASDAQ: INCR) (TASE: I
The funding may increase to NIS 107M to support the expansion of the facility in collaboration with
InterCure Ltd. INCR has shown resilience in its H1 2024 performance despite facing significant chall
NEW YORK and HERZLIYA, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TA
Thursday's session saw 337 companies set new 52-week lows.
On Friday, 497 companies set new 52-week lows.
Monday saw 825 companies set new 52-week lows.
During Friday's session, 574 stocks hit new 52-week lows.
On Wednesday, 297 companies achieved new lows for the year.
On Tuesday, 400 companies set new 52-week lows.
On Thursday, 529 companies set new 52-week lows.